Biospecifics Technologies (BSTC) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q1 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6.25 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Radnostix revenue falls 27% amid product recalls and FDA actions
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
